GLICLAZIDE ZYDUS 30 mg
The same active substance, strength and form as listed by each country’s medicines regulator. For showing a pharmacist abroad.
- Active substance
- Gliclazide
- Strength
- 30 mg
- Form
- comprimé à libération modifiée
- ATC code
- Not stated by the register
- Registered in
- France · ZYDUS FRANCE
- Prescription
- Prescription only
- CIS
- 62851449
Source: Base de données publique des médicaments · 2026-09-30
Not a prescription. Not a statement that these products are interchangeable. Products are matched on active substance, strength and kind of form only. Other ingredients, release, approved uses and the dose on the box can differ. A pharmacist or doctor decides whether one can replace another.
Listed in other countries
Bulgaria 5 matching products
| Name on the box | Strength and form | Prescription | Holder | Official record |
|---|---|---|---|---|
| Diab MRДиаб МR | 30 mg modified-release tablets · modified release tablet | Prescription only | Чайкафарма Висококачествените Лекарства АД | 20130015 |
| Ecozid MRЕкозид MR | 30 mg · prolonged - release tablets | Prescription only | ЕКОФАРМ ГРУП АД | 20180312 |
| ECOZID SRЕкозид SR | 30 mg · prolonged - release tablets | Prescription only | Екофарм Груп АД | 20120076 |
| Gliclacon SRГликлакон SR | 30 mg · prolonged - release tablets | Prescription only | ФАРМАКОНС АД | 20260279 |
| Madras MRМадрас MR | 30 mg · modified release tablet | Prescription only | Stada Arzneimittel AG | 20140046 |
Source: Bulgarian Drug Agency register (Изпълнителна агенция по лекарствата (BDA)) · 2026-08-01
Canada 8 matching products
| Name on the box | Strength and form | Prescription | Holder | Official record |
|---|---|---|---|---|
| AG-GLICLAZIDE MR | 30 mg · tablet (extended-release) | Prescription only | Angita Pharma Inc. | 02483300 |
| APO-GLICLAZIDE MR | 30 mg · tablet (extended-release) | Prescription only | Apotex Inc | 02297795 |
| DIAMICRON MR | 30 mg · tablet (extended-release) | Prescription only | Servier Canada Inc | 02242987 |
| GLICLAZIDE MR TABLETS | 30 mg · tablet (extended-release) | Prescription only | Sanis Health Inc | 02568039 |
| JAMP GLICLAZIDE-MR | 30 mg · tablet (extended-release) | Prescription only | Jamp Pharma Corporation | 02429764 |
| MINT-GLICLAZIDE MR | 30 mg · tablet (extended-release) | Prescription only | Mint Pharmaceuticals Inc | 02423286 |
2 more names not shown. Source: Drug Product Database (Health Canada) · 2026-09-30 · Contains information licensed under the Open Government Licence – Canada.
Netherlands 9 matching products
| Name on the box | Strength and form | Prescription | Holder | Official record |
|---|---|---|---|---|
| Gliclazide retard Teva 30 mg | 30 mg · tablet met gereguleerde afgifte | Prescription only | Teva B.V. (+1) | 134036 |
| DIAMICRON MR 30 mg | 30 mg · tablet met gereguleerde afgifte | Prescription only | Les Laboratoires Servier | 25617 |
| Gliclazide 30 mg PCH | 30 mg · tablet met gereguleerde afgifte | Prescription only | Pharmachemie B.V. | 34591 |
| Gliclazide Aurobindo Retard 30 mg | 30 mg · tablet met gereguleerde afgifte | Prescription only | Aurobindo Pharma B.V. | 129517 |
| Gliclazide Brillpharma 30 mg | 30 mg · tablet met verlengde afgifte | Prescription only | Brillpharma (Ireland) Limited | 114159 |
| Gliclazide Retard Viatris 30 mg | 30 mg · tablet met gereguleerde afgifte | Prescription only | Viatris Limited | 34590 |
2 more names not shown. Source: Geneesmiddeleninformatiebank (College ter Beoordeling van Geneesmiddelen (CBG-MEB)) · 2026-09-30 · Bron: College ter Beoordeling van Geneesmiddelen (CBG). De Rijksoverheid is het niet automatisch eens met de inhoud van deze site.